Net Medical XpressQ3 Profitability, Positive Cash Flow and Strengthened Balance Sheet on Growing Telemedicine Services

Net Medical XpressQ3 Profitability, Positive Cash Flow and Strengthened Balance Sheet on Growing Telemedicine Services

ALBUQUERQUE, NM — (Marketwired) — 11/13/15 — Net Medical Xpress Solutions, Inc. (OTCQB: NMXS) announced today revenue for the third quarter of 2015 of $1,010,000 vs. revenue of $1,091,000 in the third quarter of 2014. The company reported net income of $105,000 or $0.00 per share versus a net loss of ($109,000) or $0.00 per share in the third quarter of last year.For the first nine months of 2015, Net Medical reported revenue of $3,379,000 vs. revenue of $3,536,000 in the first nine months o

Net Medical Xpress Announces Q2 Profitability, Positive Cash Flow and Strengthened Balance Sheet on Growing Telemedicine Services

Net Medical Xpress Announces Q2 Profitability, Positive Cash Flow and Strengthened Balance Sheet on Growing Telemedicine Services

ALBUQUERQUE, NM — (Marketwired) — 08/17/15 — Net Medical Xpress Solutions, Inc. (OTCQB: NMXS) announced today revenue for the second quarter of 2015 of $1,128,000 vs. revenue of $1,174,000 in the second quarter of 2014. The company reported net income of $29,000 or $0.00 per share versus a net loss of ($67,000) or $0.00 per share in the second quarter of last year.For the first six months of 2015, Net Medical reported revenue of $2,368,000 vs. revenue of $2,445,000 in the first half of 2014.

Net Medical Xpress Announces Radio Series on Cancer

Net Medical Xpress Announces Radio Series on Cancer

ALBUQUERQUE, NM — (Marketwired) — 06/15/15 — Net Medical Xpress Solutions, Inc. (OTCQB: NMXS) announced today that it has approved a 12 part series of one-hour radio programs on cancer. The program will air on various stations including the CEO Network.CEO Dick Govatski said, "We are pleased to have some of the top cancer specialists in the country participate. Over 25 physicians and medical researchers will be available to discuss such topics as Children and Cancer, Basic Research, Cli